Diabetes News and Research

Latest Diabetes News and Research

Exercise improves key measures of cardiovascular health

Eight months of daily, afterschool physical activity in previously inactive 8- to 11-year-olds with obesity and overweight improved key measures of their cardiovascular health like good cholesterol levels, aerobic fitness and percent body fat, but didn't improve others like arterial stiffness, an early indicator of cardiovascular risk, investigators report.

9 Dec 2019

Experts say cancer research is making more progress that people think

The focus on a “cure for cancer” is masking progress made in extending lifespan and making cancer manageable in the long-term.

9 Dec 2019

Ethicon’s VISTASEAL Fibrin Sealant (Human) can help surgeons manage bleeding during surgery

Many patients today are entering the operating room with multiple factors that can cause disruptive bleeding during surgery, which can be challenging to manage and potentially dangerous.

9 Dec 2019

New partnership enables launch of POCare cell therapy platform within HYGEIA Group’s hospital network

Orgenesis Inc., a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary Masthercell Global, Inc., as well as localized point-of-care development and processing centers for therapeutic treatments, today announces a strategic partnership agreement between the HYGEIA Group and the Theracell–Orgenesis joint venture.

9 Dec 2019

UM Medicine launches new centers in Maryland to treat adults with neurodevelopmental disabilities

The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.

8 Dec 2019

Research shows why people with chronic illnesses turn to the 'black market' for medicines and supplies

Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the "black market" for medicines and supplies, new research shows.

6 Dec 2019

Pilot clinical trial tests new treatment for type 1 diabetes

Type 1 diabetes is a chronic condition in which the body's own immune system attacks and destroys beta cells in the pancreas. Once the beta cells are destroyed, the pancreas can no longer produce insulin. Currently, there is no cure for T1D and treatment focuses on managing blood sugar levels.

6 Dec 2019

Clinical trial demonstrates safety and effectiveness of oral drug to treat NASH

Patients with nonalcoholic steatohepatitis, a chronic liver disease and a leading cause for liver transplantation in the U.S., currently lack an approved drug therapy, but this may soon change.

6 Dec 2019

IDTechEx brings Healthcare Sensor Innovations conference to USA

IDTechEx, expert providers of emerging technology market intelligence and events, are bringing the conference on wearables and sensors in healthcare to San Jose, USA.

6 Dec 2019

New analysis suggests link between cholesterol levels and long-term risk for cardiovascular disease

The most comprehensive analysis of its kind suggests that there is a strong link between non-HDL cholesterol levels and long-term risk for cardiovascular disease in people aged under 45 years, not just at older ages.

5 Dec 2019

Early cholesterol checks could save your heart

A new study published in the journal The Lancet reports that early cholesterol checking in the 20s, for instance, would help forecast the individual’s risk of ever having a stroke or heart disease over a lifetime.

5 Dec 2019

Early diagnosis and treatment of chronic inflammation may reduce illness, save lives

Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and death worldwide.

5 Dec 2019

Mount Sinai receives $1 million grant to advance understanding of prostate cancer

The Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai has received a $1 million grant from The Arthur M. Blank Family Foundation.

5 Dec 2019

Time-restricted eating can help treat metabolic syndrome

Metabolic syndrome affects nearly 30 percent of the U.S. population, and increases the risk for type 2 diabetes, heart disease and stroke. But lifestyle interventions such as adopting a healthy diet and increasing physical exercise are difficult to maintain and, even when combined with medication, are often insufficient to fully manage the disease.

5 Dec 2019

As his wife’s caregiver, a doctor discovers what’s missing at health care’s core

Caring for someone with a serious illness stretches people spiritually and emotionally, often beyond what they might have thought possible.

5 Dec 2019

Brits betting online, eating unhealthily and drinking too much alcohol

The National Health Service (NHS) England has released its latest survey and reveals that millions of people in England are eating unhealthy foods, drinking too much alcohol, are overweight, and turned to online gambling.

4 Dec 2019

FDA-approved drug repairs gut leakiness associated with ulcerative colitis

A research team led by biomedical scientists at the University of California, Riverside, has found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut's epithelium.

4 Dec 2019

Rural women experience higher rates pregnancy complications than urban peers

Women in rural communities experience higher rates of life-threatening complications during or after childbirth than mothers in urban cities, a new study finds.

4 Dec 2019

Tulane neuroscientist receives $2.9 million NIH grant to launch the Telomere Research Network

Tulane University neuroscientist Dr. Stacy Drury will launch the Telomere Research Network to establish best practices for measuring telomere length and how it can be used as a sentinel of aging-related disease risk.

4 Dec 2019

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. Food and Drug Administration, according to a City of Hope-led study.

4 Dec 2019

Diabetes News and Research

Latest Diabetes News and Research

Exercise improves key measures of cardiovascular health

Experts say cancer research is making more progress that people think

Ethicon’s VISTASEAL Fibrin Sealant (Human) can help surgeons manage bleeding during surgery

New partnership enables launch of POCare cell therapy platform within HYGEIA Group’s hospital network

UM Medicine launches new centers in Maryland to treat adults with neurodevelopmental disabilities

Research shows why people with chronic illnesses turn to the 'black market' for medicines and supplies

Pilot clinical trial tests new treatment for type 1 diabetes

Clinical trial demonstrates safety and effectiveness of oral drug to treat NASH

IDTechEx brings Healthcare Sensor Innovations conference to USA

New analysis suggests link between cholesterol levels and long-term risk for cardiovascular disease

Early cholesterol checks could save your heart

Early diagnosis and treatment of chronic inflammation may reduce illness, save lives

Mount Sinai receives $1 million grant to advance understanding of prostate cancer

Time-restricted eating can help treat metabolic syndrome

As his wife’s caregiver, a doctor discovers what’s missing at health care’s core

Brits betting online, eating unhealthily and drinking too much alcohol

FDA-approved drug repairs gut leakiness associated with ulcerative colitis

Rural women experience higher rates pregnancy complications than urban peers

Tulane neuroscientist receives $2.9 million NIH grant to launch the Telomere Research Network

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in